Back to Search Start Over

Short Communication - Study on quality and efficacy of commercial tylosin and doxycycline products against local isolates of mycoplasma in broilers.

Authors :
Riazuddin -
Khan S
Imtiaz N
Aslam S
Ahmad S
Khan H
Rabbani M
Muhammad J
Tanveer ZI
Ali S
Source :
Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2017 Mar; Vol. 30 (2), pp. 541-549.
Publication Year :
2017

Abstract

The present study was conducted to investigate the quality and efficacy of commercially available preparations of tylosin and doxycycline available in the local market at Peshawar for poultry. In vitro and in vivo, tests were conducted to check the quality of these antimicrobial drugs. In vitro quality control test was performed by High performance liquid chromatographic (HPLC) and micro dilution method. In vivo, efficacy of the test drugs was checked in broilers infected with Mycoplasma gallisepticum. Results of HPLC indicated that test drug-2 contains doxycycline hydrochloride within specified limits but contain high quantity of active ingredient (Tylosin tartrate 120%). Recovery percentage of test drugs (3, 4, 5) were below the pharmacopoeial limit, which contained low quantity of tylosin tartrate (85%, 87.5%, 85%) respectively however, percent recovery of doxycycline were in the appropriate limits. All the tested drugs were effective against Mycoplasma gallisepticum and showed minimum inhibitory concentration (MIC) at 1.9μg/ml. The in vivo result indicated that all tested drugs decreased morbidity and mortality in infected chicks. The birds treated with test drugs (3 and 5) showed mortality of 9.5%, which was slightly higher than the other test groups. The current study suggested that there are incidences of substandard drugs in Pakistan and the drug regularity authorities should take strict actions against the manufacturing companies.

Details

Language :
English
ISSN :
1011-601X
Volume :
30
Issue :
2
Database :
MEDLINE
Journal :
Pakistan journal of pharmaceutical sciences
Publication Type :
Academic Journal
Accession number :
28649082